Норвегия - норвежский - Statens legemiddelverk

mylan ab - imatinib - tablett, filmdrasjert - 400 mg

Норвегия - норвежский - Statens legemiddelverk

mylan ab - imatinib - tablett, filmdrasjert - 100 mg

Норвегия - норвежский - Statens legemiddelverk

sandoz - københavn - efavirenz / emtricitabin / tenofovirdisoproksilsuksinat - tablett, filmdrasjert - 600 mg / 200 mg / 245 mg

Европейский союз - норвежский - EMA (European Medicines Agency)

accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastiske midler - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.

Норвегия - норвежский - Statens legemiddelverk

sandoz - københavn - dasatinib - tablett, filmdrasjert - 70 mg

Норвегия - норвежский - Statens legemiddelverk

sandoz - københavn - dasatinib - tablett, filmdrasjert - 20 mg

Норвегия - норвежский - Statens legemiddelverk

sandoz - københavn - dasatinib - tablett, filmdrasjert - 50 mg

Норвегия - норвежский - Statens legemiddelverk

sandoz - københavn - sunitinib - kapsel, hard - 12.5 mg

Норвегия - норвежский - Statens legemiddelverk

sandoz - københavn - sunitinib - kapsel, hard - 25 mg

Норвегия - норвежский - Statens legemiddelverk

sandoz - københavn - sunitinib - kapsel, hard - 50 mg